SCHEMBL5607008

SCHEMBL5607008

CC(=Cc1ccc(OCc2ccccc2)cc1)C(=O)O.[CsH]

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.61
MAOB P27338 2/20 0.59
GSK3B P49841 3/20 0.57
BACE1 P56817 3/20 0.57
AKR1C3 P42330 1/20 0.57
NPC1 O15118 3/20 0.56
RAB9A P51151 3/20 0.56
KDM4E B2RXH2 2/20 0.56
GAA P10253 1/20 0.56
MAPT P10636 1/20 0.56
NR4A1 P22736 1/20 0.54
NR4A2 P43354 1/20 0.54
NR4A3 Q92570 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.53
PTGS1 P23219 2/20 0.52
PTGS2 P35354 2/20 0.52
ALOX5 P09917 1/20 0.52
CASP3 P42574 1/20 0.52
SENP8 Q96LD8 1/20 0.52
SENP7 Q9BQF6 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3662420 0.98 NR1H4 (0.63) NR1H4MAOBGSK3BBACE1AKR1C3
SCHEMBL3662418 0.98 NR1H4 (0.63) NR1H4MAOBGSK3BBACE1AKR1C3
SCHEMBL5608229 0.97 NR1H4 (0.61) NR1H4MAOBGSK3BBACE1AKR1C3
SCHEMBL5606693 0.97 NR1H4 (0.61) NR1H4MAOBGSK3BBACE1AKR1C3
SCHEMBL5606251 0.97 NR1H4 (0.61) NR1H4MAOBGSK3BBACE1AKR1C3
Ammonia Solution, Strong SCHEMBL5606811 0.97 NR1H4 (0.61) NR1H4MAOBGSK3BBACE1AKR1C3
SCHEMBL5607888 0.97 NR1H4 (0.61) NR1H4MAOBGSK3BBACE1AKR1C3
SCHEMBL5606892 0.97 NR1H4 (0.61) NR1H4MAOBGSK3BBACE1AKR1C3
SCHEMBL5607704 0.97 NR1H4 (0.61) NR1H4MAOBGSK3BBACE1AKR1C3
Methylamine SCHEMBL5606887 0.96 NR1H4 (0.60) NR1H4MAOBGSK3BBACE1AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed
EP-1687250-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS Takasago International Corporation (JP) 2006-08-09 EP disclosed
WO-2005051882-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids ALDH1A2, ALDH1A3, GRHPR NR1H4 220/4885MAOB 1990/4885GSK3B 2848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.